Two Surgical Techniques for Essure Device Ablation: The Hysteroscopic Way and the Laparoscopic Way by Salpingectomy with Tubal Interstitial Resection.


Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
Historique:
received: 26 06 2018
revised: 19 07 2018
accepted: 20 07 2018
pubmed: 1 8 2018
medline: 6 8 2019
entrez: 1 8 2018
Statut: ppublish

Résumé

To describe 2 different surgical techniques for Essure removal on the same patient: the hysteroscopic and laparoscopic techniques. An educational video approved by the local institutional review board (Canadian Task Force classification III). A university hospital (University Hospital of Strasbourg, Strasbourg, France). A 46-year-old woman with many symptoms after Essure device implantation. An ultrasound found a right implant in the uterine cavity and a left intratubal implant. The first step was the hysteroscopic removal of the right implant. We viewed the 2 internal and external spirals, allowing the gripping of the whole device without risking any fragmentation or tubal lesion. The second step was bilateral salpingectomy with resection of the left interstitial tubal portion. We longitudinally incised the antimesial edge of the fallopian tube 2 to 3 cm from the tubal serous to the implant contact. A circumferential incision was performed at the uterine horn to circumscribe the interstitial tubal portion. The implant was released from the surrounding tissue. It was gently pulled to completely extract it and avoid spiral fragmentation. Then, we performed a bilateral total salpingectomy. An X-ray of the implants and pelvis was performed to ensure complete removal of the device. We made an X-stitch in the uterine horn to avoid the risk of fistula. More and more patients are asking for the removal of their implants. The surgical technique has to be adapted to the location of the implants and has to allow their complete removal to avoid leaving fragments that can cause the persistence of side effects.

Identifiants

pubmed: 30064007
pii: S1553-4650(18)30365-0
doi: 10.1016/j.jmig.2018.07.017
pii:
doi:

Types de publication

Case Reports Journal Article Video-Audio Media

Langues

eng

Pagination

603

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Marion Tissot (M)

Department of Surgical Gynecology, University Hospital of Strasbourg, Strasbourg, France (all authors).

Solène Petry (S)

Department of Surgical Gynecology, University Hospital of Strasbourg, Strasbourg, France (all authors).. Electronic address: solene.petry@hotmail.fr.

Lise Lecointre (L)

Department of Surgical Gynecology, University Hospital of Strasbourg, Strasbourg, France (all authors).

Emilie Faller (E)

Department of Surgical Gynecology, University Hospital of Strasbourg, Strasbourg, France (all authors).

Jean-Jacques Baldauf (JJ)

Department of Surgical Gynecology, University Hospital of Strasbourg, Strasbourg, France (all authors).

Chérif Akladios (C)

Department of Surgical Gynecology, University Hospital of Strasbourg, Strasbourg, France (all authors).

Thomas Boisrame (T)

Department of Surgical Gynecology, University Hospital of Strasbourg, Strasbourg, France (all authors).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH